FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2756067458> ?p ?o ?g. }

• W2756067458 endingPage "1216" @default.
• W2756067458 startingPage "1205" @default.
• W2756067458 abstract "Background and Purpose An appropriate inflammatory response is necessary for cardiac healing after acute myocardial infarction (MI). Resolvin E1 (RvE1) is an anti‐inflammatory and pro‐resolution lipid mediator derived from eicosapentaenoic acid. Here we have investigated the effects of RvE1 on the recovery of cardiac function after MI in mice. Experimental Approach Acute MI was induced by surgical ligation of the left anterior descending artery in male C57BL/6 mice. RvE1 (5 ng·g −1 ·day −1 ; i.p.) was given to mice at different times following MI. Cardiac function was monitored by transthoracic echocardiography at days 3, 7 and 14 after MI. Effects of RvE1 on the migration of subpopulations of monocytes/macrophages (Mos/Mps, Ly6C hi and Ly6C low ) were examined by flow cytometry and transwell assay. Key Results RvE1 administration from days 1 to 7 post‐MI improved cardiac function, whereas treatment from days 7 to 14 markedly inhibited recovery of cardiac function. Early treatment with RvE1 post‐MI suppressed the infiltration of dominant Ly6C hi Mos/Mps and secretion of pro‐inflammatory cytokines in injured hearts, which protected cardiomyocytes against apoptosis in the peri‐infarct zones. Contrastingly, treatment with RvE1 1 week after MI decreased infiltration of Ly6C low Mos/Mps and expression of pro‐angiogenic factors in cardiac tissue, consequently reducing neovascularization in the peri‐infarct zones. Additionally, RvE1 inhibited Mp migration by activating ChemR23 receptors. Conclusion and Implications Treatment with RvE1 during the initial 7 days after MI facilitated cardiac healing by suppressing pro‐inflammatory cytokine secretion, indicating that RvE1 may serve as an early therapeutic agent for acute MI. Linked Articles This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc" @default.
• W2756067458 created "2017-09-25" @default.
• W2756067458 creator A5000452085 @default.
• W2756067458 creator A5000510528 @default.
• W2756067458 creator A5001078737 @default.
• W2756067458 creator A5019049860 @default.
• W2756067458 creator A5030218241 @default.
• W2756067458 creator A5032432567 @default.
• W2756067458 creator A5032705392 @default.
• W2756067458 creator A5035197459 @default.
• W2756067458 creator A5036287047 @default.
• W2756067458 creator A5041382840 @default.
• W2756067458 creator A5053921240 @default.
• W2756067458 creator A5062170722 @default.
• W2756067458 creator A5065312383 @default.
• W2756067458 creator A5066716873 @default.
• W2756067458 creator A5067355359 @default.
• W2756067458 creator A5082174447 @default.
• W2756067458 creator A5085758047 @default.
• W2756067458 date "2017-10-22" @default.
• W2756067458 modified "2023-10-15" @default.
• W2756067458 title "Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice" @default.
• W2756067458 cites W1191698374 @default.
• W2756067458 cites W1542864268 @default.
• W2756067458 cites W1544184390 @default.
• W2756067458 cites W1556346244 @default.
• W2756067458 cites W1593555249 @default.
• W2756067458 cites W1596457615 @default.
• W2756067458 cites W1888470382 @default.
• W2756067458 cites W1951446444 @default.
• W2756067458 cites W1970136916 @default.
• W2756067458 cites W1973404873 @default.
• W2756067458 cites W1973636045 @default.
• W2756067458 cites W1980493203 @default.
• W2756067458 cites W1981044204 @default.
• W2756067458 cites W1988697119 @default.
• W2756067458 cites W2005400104 @default.
• W2756067458 cites W2025802469 @default.
• W2756067458 cites W2043469918 @default.
• W2756067458 cites W2051521659 @default.
• W2756067458 cites W2089477170 @default.
• W2756067458 cites W2090609282 @default.
• W2756067458 cites W2100974788 @default.
• W2756067458 cites W2104627091 @default.
• W2756067458 cites W2106557745 @default.
• W2756067458 cites W2107653986 @default.
• W2756067458 cites W2109549810 @default.
• W2756067458 cites W2119610102 @default.
• W2756067458 cites W2135647797 @default.
• W2756067458 cites W2137361420 @default.
• W2756067458 cites W2153406260 @default.
• W2756067458 cites W2157758580 @default.
• W2756067458 cites W2158550197 @default.
• W2756067458 cites W2159803625 @default.
• W2756067458 cites W2162465757 @default.
• W2756067458 cites W2163134721 @default.
• W2756067458 cites W2165421711 @default.
• W2756067458 cites W2177000179 @default.
• W2756067458 cites W2178888160 @default.
• W2756067458 cites W2189963137 @default.
• W2756067458 cites W2194756172 @default.
• W2756067458 cites W2196064518 @default.
• W2756067458 cites W2196303538 @default.
• W2756067458 cites W2253234903 @default.
• W2756067458 cites W2267092907 @default.
• W2756067458 cites W2519255701 @default.
• W2756067458 cites W2525540730 @default.
• W2756067458 cites W2547755905 @default.
• W2756067458 cites W2579756956 @default.
• W2756067458 cites W4256570545 @default.
• W2756067458 doi "https://doi.org/10.1111/bph.14041" @default.
• W2756067458 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5866979" @default.
• W2756067458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28925017" @default.
• W2756067458 hasPublicationYear "2017" @default.
• W2756067458 type Work @default.
• W2756067458 sameAs 2756067458 @default.
• W2756067458 citedByCount "40" @default.
• W2756067458 countsByYear W27560674582018 @default.
• W2756067458 countsByYear W27560674582019 @default.
• W2756067458 countsByYear W27560674582020 @default.
• W2756067458 countsByYear W27560674582021 @default.
• W2756067458 countsByYear W27560674582022 @default.
• W2756067458 countsByYear W27560674582023 @default.
• W2756067458 crossrefType "journal-article" @default.
• W2756067458 hasAuthorship W2756067458A5000452085 @default.
• W2756067458 hasAuthorship W2756067458A5000510528 @default.
• W2756067458 hasAuthorship W2756067458A5001078737 @default.
• W2756067458 hasAuthorship W2756067458A5019049860 @default.
• W2756067458 hasAuthorship W2756067458A5030218241 @default.
• W2756067458 hasAuthorship W2756067458A5032432567 @default.
• W2756067458 hasAuthorship W2756067458A5032705392 @default.
• W2756067458 hasAuthorship W2756067458A5035197459 @default.
• W2756067458 hasAuthorship W2756067458A5036287047 @default.
• W2756067458 hasAuthorship W2756067458A5041382840 @default.
• W2756067458 hasAuthorship W2756067458A5053921240 @default.
• W2756067458 hasAuthorship W2756067458A5062170722 @default.
• W2756067458 hasAuthorship W2756067458A5065312383 @default.
• W2756067458 hasAuthorship W2756067458A5066716873 @default.

• next